*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter - as a primary diagnosis code | T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.53 | |
| Readmission Rate (%) | 19.2 | |
| Unplanned Readmission Rate (%) | 13.7 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 104 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter in DRG | 70.75 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 2.43 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 17.48 | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 13.59 | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $364,318 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $1,440 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $3,503 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $2,094,769 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $20,142 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 69.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 292,335 | ||||
| Total Hospitalizations with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 6,238 | ||||
| DRG Share of Total Hospitalizations | 0.89 | ||||
| % of Total ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter in DRG | 12.18 | ||||
| Avg LOS at DRG | 2.96 | ||||
| Avg LOS with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 2.9 | ||||
| Readmission Rate at DRG | 19.18 | ||||
| Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 15.8 | ||||
| Unplanned Readmission Rate at DRG | 13.96 | ||||
| Unplanned Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 11.68 | ||||
| Total Medicare payments at DRG | $1,347,436,356 | ||||
| Total Medicare payments with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $29,069,232 | ||||
| Total Medicare payment per Day at DRG | $1,557 | ||||
| Total Medicare payment per Day with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $1,604 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,609 | ||||
| Total Medicare payment per Hospitalization with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $4,660 | ||||
| Total Medicare Charges at DRG | $7,385,462,160 | ||||
| Total Medicare Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $155,525,418 | ||||
| Avg Charges at DRG | $25,264 | ||||
| Avg Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $24,932 | ||||
| Mortality Rate at DRG | 0.57 | ||||
| Mortality Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 11.55 | ||||
| SNF Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 14.92 | ||||
| Home Discharge Rate at DRG | 63.79 | ||||
| Home Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 58.7 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 1,406 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter in DRG | 2.75 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 3.61 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 19.35 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 14.14 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $7,791,035 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $1,536 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $5,541 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $39,455,386 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $28,062 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 18.78 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 50.92 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,522,684 | ||||
| Total Hospitalizations with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 733 | ||||
| DRG Share of Total Hospitalizations | 4.63 | ||||
| % of Total ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter in DRG | 1.43 | ||||
| Avg LOS at DRG | 2.52 | ||||
| Avg LOS with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 3.05 | ||||
| Readmission Rate at DRG | 9.03 | ||||
| Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 10.55 | ||||
| Unplanned Readmission Rate at DRG | 3.35 | ||||
| Unplanned Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 5.63 | ||||
| Total Medicare payments at DRG | $17,672,828,347 | ||||
| Total Medicare payments with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $8,918,986 | ||||
| Total Medicare payment per Day at DRG | $4,606 | ||||
| Total Medicare payment per Day with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $3,983 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
| Total Medicare payment per Hospitalization with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $12,168 | ||||
| Total Medicare Charges at DRG | $91,836,200,128 | ||||
| Total Medicare Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $47,324,364 | ||||
| Avg Charges at DRG | $60,312 | ||||
| Avg Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $64,563 | ||||
| Mortality Rate at DRG | 0.05 | ||||
| Mortality Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 23.53 | ||||
| SNF Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 32.47 | ||||
| Home Discharge Rate at DRG | 30.67 | ||||
| Home Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 25.78 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | DRG 313: CHEST PAIN | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 150,404 | ||||
| Total Hospitalizations with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 535 | ||||
| DRG Share of Total Hospitalizations | 0.46 | ||||
| % of Total ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter in DRG | 1.04 | ||||
| Avg LOS at DRG | 3.31 | ||||
| Avg LOS with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 3.48 | ||||
| Readmission Rate at DRG | 20.72 | ||||
| Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 19.25 | ||||
| Unplanned Readmission Rate at DRG | 14.7 | ||||
| Unplanned Readmission Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 14.23 | ||||
| Total Medicare payments at DRG | $938,855,823 | ||||
| Total Medicare payments with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $3,357,839 | ||||
| Total Medicare payment per Day at DRG | $1,886 | ||||
| Total Medicare payment per Day with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $1,803 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,242 | ||||
| Total Medicare payment per Hospitalization with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $6,276 | ||||
| Total Medicare Charges at DRG | $5,236,903,865 | ||||
| Total Medicare Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $18,539,923 | ||||
| Avg Charges at DRG | $34,819 | ||||
| Avg Charges with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | $34,654 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 13.12 | ||||
| SNF Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 15.33 | ||||
| Home Discharge Rate at DRG | 52.08 | ||||
| Home Discharge Rate with ICD T447X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter | 52.71 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 156 |
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 149 |
| CENTRA VIRGINIA BAPTIST HOSPITAL | 3300 RIVERMONT AVE | LYNCHBURG | VA | 24503 | 145 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 45 |
| Dr. BRADLEY MARK SHORT | 3905 BROOKEN HILL DR | FORT SMITH | AR | 72908 | 35 |
| Dr. ROBERT SIEW | 301 W HUNTINGTON DR | ARCADIA | CA | 91007 | 22 |